Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (171-180 of 289) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Immunology|March 1, 1981
A method for following human lymphocyte traffic using indium-111 oxine labellingJ Wagstaff, C Gibson, N Thatcher, et al.
International Journal of Cancer|October 31, 2000
O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II studyM R Middleton, S M Lee, A Arance, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary resultsN Thatcher, P Taylor, K B Carroll, et al.
British Journal of Cancer|July 1, 1989
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchusN Thatcher, M Lind, R Stout, et al.
British Journal of Cancer|December 17, 2003
Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility studyH Anderson, J M Addington-Hall, M D Peake, et al.
Oncogene|September 7, 1995
Alternate splicing produces a novel cyclin D1 transcriptD C Betticher, N Thatcher, H J Altermatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working PartyN Thatcher, D J Girling, P Hopwood, et al.
European Cytokine Network|May 1, 1993
A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studiesA K Ghosh, N K Smith, J Prendiville, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agentsDean Y Maeda, Wanda Williams, Wes E Kim, et al.
British Journal of Cancer|March 29, 2000
A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaM R Middleton, P Lorigan, J Owen, et al.
Pageof 29

Showing results (171-180 of 289) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Immunology|March 1, 1981
A method for following human lymphocyte traffic using indium-111 oxine labellingJ Wagstaff, C Gibson, N Thatcher, et al.
International Journal of Cancer|October 31, 2000
O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II studyM R Middleton, S M Lee, A Arance, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary resultsN Thatcher, P Taylor, K B Carroll, et al.
British Journal of Cancer|July 1, 1989
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchusN Thatcher, M Lind, R Stout, et al.
British Journal of Cancer|December 17, 2003
Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility studyH Anderson, J M Addington-Hall, M D Peake, et al.
Oncogene|September 7, 1995
Alternate splicing produces a novel cyclin D1 transcriptD C Betticher, N Thatcher, H J Altermatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working PartyN Thatcher, D J Girling, P Hopwood, et al.
European Cytokine Network|May 1, 1993
A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studiesA K Ghosh, N K Smith, J Prendiville, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agentsDean Y Maeda, Wanda Williams, Wes E Kim, et al.
British Journal of Cancer|March 29, 2000
A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaM R Middleton, P Lorigan, J Owen, et al.
Pageof 29